Atherosclerosis and thromboembolic risk in atrial fibrillation: focus on peripheral vascular disease.

about

Role of the CHADS Score in the Evaluation of Carotid Atherosclerosis in Patients with Atrial Fibrillation Undergoing Carotid Artery Ultrasonography Clinical and Imaging Characteristics of Cerebral Infarction in Patients with Nonvalvular Atrial Fibrillation Combined with Cerebral Artery Stenosis

P2860

Q58766109-18FDE48E-E55B-49EA-977C-4ADDEB78383A Q58805695-3398D488-0690-47C8-9D08-C11ECE38EF3E

P2860

Atherosclerosis and thromboembolic risk in atrial fibrillation: focus on peripheral vascular disease.

Item

http://www.wikidata.org/entity/Q38065252

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Atherosclerosis and thromboemb ...... n peripheral vascular disease.

@en

type

Item

label

Atherosclerosis and thromboemb ...... n peripheral vascular disease.

@en

prefLabel

Atherosclerosis and thromboemb ...... n peripheral vascular disease.

@en

P1476

Atherosclerosis and thromboemb ...... on peripheral vascular disease

@en

P2093

Eva Jover

http://www.w3.org/2001/XMLSchema#string

Francisco Marín

http://www.w3.org/2001/XMLSchema#string

Gregory Y H Lip

http://www.w3.org/2001/XMLSchema#string

Mariano Valdés

http://www.w3.org/2001/XMLSchema#string

P2860

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

Atherosclerosis of the descending aorta predicts cardiovascular events: a transesophageal echocardiography study

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study

A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin

Peripheral arterial disease detection, awareness, and treatment in primary care

High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis

Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy

Atrial fibrillation and stroke prevention

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

P304

274-290

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.3109/07853890.2012.732702

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Silvia Montoro-García

V Roldan

P577

2012-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23216106

http://www.w3.org/2001/XMLSchema#string

P921

thromboembolism

Atherosclerosis and thromboembolic risk in atrial fibrillation: focus on peripheral vascular disease.

about

P2860

P2860

Atherosclerosis and thromboembolic risk in atrial fibrillation: focus on peripheral vascular disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921